International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.14220056
Case Report
Myelomatous Pleural Effusion- A Rare Case
Abstract

Plasma cell disorders, including multiple myeloma, are a group of diseases characterized by the abnormal proliferation of plasma cells. While pleural effusion is uncommon in multiple myeloma, it may result from myelomatous infiltration of the pleura or heart failure due to amyloidosis. In this report, we present a case of a 62-yearold male who was diagnosed with multiple myeloma after presenting with progressive dyspnea, cough, and generalized weakness over two months. Physical examination revealed diminished breath sounds over the left hemithorax. Chest X-ray and ultrasonography confirmed moderate pleural effusion, with 1000 mL of serosanguinous fluid aspirated. Pleural fluid analysis showed lymphocytic exudative effusion, elevated adenosine deaminase (76 IU/L), and plasma cell dyscrasias, indicative of multiple myeloma. Blood tests revealed anemia (Hb 7.5 g/dL) and renal impairment (serum creatinine 2.4 mg/dL). Imaging studies identified multiple lytic lesions in the skull and compression fractures in the thoraco-lumbar spine. Bone marrow aspirate showed 46% plasma cells. The patient was diagnosed with multiple myeloma and initiated on chemotherapy, showing clinical improvement with no recurrence of pleural effusion on follow-up. This case emphasizes the rarity of myelomatous pleural effusion and highlights the importance of early diagnosis and appropriate management. Treatment typically involves chemotherapy, with supportive care to manage symptoms, though the prognosis remains poor in cases of myelomatous pleural effusion.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1592 Views
171 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved